Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease

Bone Marrow Transplant. 2004 May;33(10):1065-6. doi: 10.1038/sj.bmt.1704485.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Amphotericin B / therapeutic use*
  • Antifungal Agents / therapeutic use*
  • Aspergillosis / complications
  • Aspergillosis / therapy*
  • Caspofungin
  • Chronic Disease / therapy
  • Drug Therapy, Combination
  • Echinocandins
  • Female
  • Graft vs Host Disease / therapy*
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Lipopeptides
  • Lung / microbiology*
  • Middle Aged
  • Peptides, Cyclic / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Tomography, X-Ray Computed
  • Transplantation, Homologous / adverse effects
  • Treatment Outcome
  • Triazoles / therapeutic use*
  • Voriconazole
  • Zygomycosis / complications
  • Zygomycosis / therapy*

Substances

  • Antifungal Agents
  • Echinocandins
  • Immunosuppressive Agents
  • Lipopeptides
  • Peptides, Cyclic
  • Pyrimidines
  • Triazoles
  • Amphotericin B
  • Caspofungin
  • Voriconazole